Racial Differences in Resistance to P2Y(12) Receptor Antagonists in Type 2 Diabetic Subjects

Although resistance to the P2Y(12) antagonist clopidogrel is linked to altered drug metabolism, some studies suggest that these pharmacokinetic abnormalities only partially account for drug resistance. To circumvent pharmacokinetic complications and target P2Y(12) receptor function we applied the di...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Cleator, John H., Duvernay, Matthew T., Holinstat, Michael, Colowick, Nancy E., Hudson, Willie J., Song, Yanna, Harrell, Frank E., Hamm, Heidi E.
Format: Artigo
Idioma:Inglês
Publicat: The American Society for Pharmacology and Experimental Therapeutics 2014
Matèries:
Cardiovascular
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4165026/
https://ncbi.nlm.nih.gov/pubmed/25052834
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.114.215616
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars